Population‐Based Validation Results From the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) Study

Documenti analoghi

• Infrequent Resolution of Vaso‐Occlusive Crises in Routine Clinical Care Among Patients Mimicking the Exa‐Cel Trial Population: A Cohort Study of Medicaid Enrollees
  di: Mufaddal Mahesri, et al.
  Pubblicazione: (2024)
• Association Discovery Approach in Healthcare Big Data to Identify Drug Safety and Drug Repurposing Signals
  di: George S. Q. Tan, et al.
  Pubblicazione: (2025)
• Therapeutic Targeting of MELK by Repurposed Drugs Netarsudil and Dutasteride Suppresses Triple‐Negative Breast Cancer Cell Progression: Evidence From Molecular Simulations and Functional Validations
  di: Arisha Arora, et al.
  Pubblicazione: (2025)
• Repurposing Drugs for Malaria through a Human Dose Prediction: A Case Study with Berzosertib
  di: Devasha Redhi, et al.
  Pubblicazione: (2026)
• Correction to “Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing”
  Pubblicazione: (2025)